When Skin Cancer Returns: How Mohs Surgery Effectively Tackles Stubborn Lesions

Hearing that your skin cancer has come back is alarming, and the reality is that a recurrence is a more serious situation than the original diagnosis. The tissue has already been cut into, scar tissue hides the cancer’s edges, and the tumor has proven it can survive removal. 

Standard treatment methods struggle with these cases because the landmarks they rely on have been disrupted. Mohs surgery was designed to handle that complexity.

Our board-certified dermatologists and Mohs surgeons at Vivida Dermatology treat recurrent skin cancers at our offices in Las Vegas and Henderson, Nevada, and St. George, Utah.

Risk of another BCC or recurrence after treatment

Having one basal cell carcinoma (BCC) significantly raises the odds of developing another. According to the NCCN Basal Cell Skin Cancer, Version 2.2024 guidelines, an estimated 30%-50% of people with BCC develop another BCC within five years, a risk roughly 10 times higher than the general population. 

A 2024 retrospective study reviewed records from 934 people with BCC and compared 133 who met the study criteria, including 55 with local recurrence after surgical excision. Most repeat tumors were detected within the first three years. Higher risk was associated with older age, tumors larger than 2 cm, a longer interval between diagnosis and complete excision, and factors such as immunosuppression, prior radiotherapy, and malignancy.

Why recurrent skin cancer is harder to treat

A cancer that comes back after treatment isn’t the same situation as a brand-new tumor on untouched skin. Several factors complicate the picture:

• Scar tissue from the first treatment obscures the cancer’s borders
• The tumor may have grown deeper or wider beneath the healed surface
• Previous surgery or radiation changed the tissue architecture
• The cancer has already demonstrated aggressive behavior by surviving initial treatment

These factors make it harder to see where the cancer ends and healthy tissue begins, which is exactly the problem Mohs surgery is designed to solve.

Mohs and recurrent skin cancer

For previously untreated skin cancers, Mohs achieves cure rates up to 99%. For recurrent cancers, that number drops somewhat but still sits around 94%, well ahead of other treatment options for tumors that have already come back.

The advantage comes from how Mohs examines tissue. Your surgeon removes one thin layer, processes it, and maps it on-site, then examines nearly the entire outer edge under a microscope. Cancer hiding beneath scar tissue, extending along an unexpected path, or growing deeper than the surface suggests gets caught because the surgeon examines the full margin rather than sampling sections of it.

For recurrent cancers specifically, that thoroughness is critical. The irregular growth patterns that come with recurrence make sampling-based methods riskier, since they’re more likely to miss cancer cells tucked into scar tissue or growing along altered tissue planes.

After Mohs: reducing the risk of another recurrence

Clearing a recurrent cancer is the immediate goal, but long-term monitoring becomes even more of a priority afterward. Your dermatologist will likely recommend more frequent skin checks, typically two to three times a year rather than annually.

Daily sun protection also takes on added urgency. Broad-spectrum sunscreen, protective clothing, and avoiding peak ultraviolet (UV) hours all reduce the cumulative damage that drives new cancers. 

Since having one recurrence raises your risk profile, staying consistent with these habits and keeping up with your screening schedule protects the investment your surgery made.

Recurrent skin cancer treatment in Las Vegas, Henderson, and St. George

A cancer that comes back needs a treatment approach built for the added complexity. To discuss your situation or schedule an evaluation, contact one of our offices today.